acut volum off-set lower margin highlight behavior volum wage
pressur drive softer ebitda oct saw strength acut care
volum use premium-pay temporari contract labor accommod
strong demand visibl elev volum experienc tight labor
condit market short-term variabl cost labor result neg oper
leverag lower ebitda said management seem acknowledg underli wage
growth remain low single-digit rang may read hospit provid
report tue price three item weigh higher er volum uptick
uninsur volum slight acuiti dilut total volum outpac surgic volum
pleas underli volum strength acut busi management recogn
lost earn opportun expect drive greater effici better oper margin
near-term overal narrow acut geograph footprint may less
volum price read hospit oper upcom result
still wait clariti higher behavior volum overal management note intern
view total compani ebitda fairli close consensu describ shortfal
relat behavior segment acut segment driven anoth
quarter soft behavior volum see figur management remain focus restor volum
driver revenu higher hesit provid color expect
posit side lo seem stabil allow top-lin grow deliv
volum growth look addit clariti trajectori behavior busi
host investor meet compani pa headquart mid-novemb
lower usd
return equiti ttm
estim follow result revis guidanc lower ebitda
link barclay live interact chart
bn bn ebitda bn bn pt decreas
target multipl new ebitda maintain ew volatil
continu within result year
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
perform well howev behavior segment
struggl hit same-stor growth target due
tight labor market clinician drag ebitda
behavior volum same-stor revenu rebound
hit growth target lead stronger
ebitda growth multipl expans
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
behavior growth deceler difficulti
recruit retain clinician persist lead
weaker expect ebitda
acut earningscommentnet bnadjust proport revis epsadjust mln barclay
 incom statement total wage oper rental high-tech ebitda incom ebit expens tax rate ep share barclay
steve valiquett patrick feeley herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli
indirectli relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
